Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 76660-37-2 | MDL No. : | MFCD09152747 |
Formula : | C10H8BrN3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NZWKWSKOAISTNU-UHFFFAOYSA-N |
M.W : | 266.09 | Pubchem ID : | 11659000 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 60.65 |
TPSA : | 61.03 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.45 cm/s |
Log Po/w (iLOGP) : | 2.06 |
Log Po/w (XLOGP3) : | 2.08 |
Log Po/w (WLOGP) : | 2.62 |
Log Po/w (MLOGP) : | 1.5 |
Log Po/w (SILICOS-IT) : | 1.92 |
Consensus Log Po/w : | 2.04 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.26 |
Solubility : | 0.146 mg/ml ; 0.000549 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.99 |
Solubility : | 0.272 mg/ml ; 0.00102 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.41 |
Solubility : | 0.0105 mg/ml ; 0.0000394 mol/l |
Class : | Moderately soluble |
PAINS : | 1.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.99 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1185158-29-5 ]
5-Bromo-2-(4-nitrophenoxy)pyrimidine
Similarity: 0.87
[ 926304-76-9 ]
Methyl 4-((5-bromopyrimidin-2-yl)oxy)benzoate
Similarity: 0.77
[ 41244-53-5 ]
2,4-Bis(benzyloxy)-5-bromopyrimidine
Similarity: 0.72
[ 60722-67-0 ]
2-(Phenylmethoxy)-4-pyrimidinamine
Similarity: 0.68
[ 1185158-29-5 ]
5-Bromo-2-(4-nitrophenoxy)pyrimidine
Similarity: 0.87
[ 926304-76-9 ]
Methyl 4-((5-bromopyrimidin-2-yl)oxy)benzoate
Similarity: 0.77
[ 41244-53-5 ]
2,4-Bis(benzyloxy)-5-bromopyrimidine
Similarity: 0.72
[ 1185158-29-5 ]
5-Bromo-2-(4-nitrophenoxy)pyrimidine
Similarity: 0.87
[ 926304-76-9 ]
Methyl 4-((5-bromopyrimidin-2-yl)oxy)benzoate
Similarity: 0.77
[ 41244-53-5 ]
2,4-Bis(benzyloxy)-5-bromopyrimidine
Similarity: 0.72
[ 148214-56-6 ]
5-Bromo-2-methoxypyrimidin-4-amine
Similarity: 0.69
[ 60722-67-0 ]
2-(Phenylmethoxy)-4-pyrimidinamine
Similarity: 0.68
[ 1004524-64-4 ]
2-((4-(Aminomethyl)benzyl)oxy)pyrimidin-4-amine
Similarity: 0.67
[ 1185158-29-5 ]
5-Bromo-2-(4-nitrophenoxy)pyrimidine
Similarity: 0.87
[ 926304-76-9 ]
Methyl 4-((5-bromopyrimidin-2-yl)oxy)benzoate
Similarity: 0.77
[ 41244-53-5 ]
2,4-Bis(benzyloxy)-5-bromopyrimidine
Similarity: 0.72